
Olmibid Trio 40mg/5mg/12.5mg Tablet
Marketer
Eswar Therapeutics Pvt Ltd
Salt Composition
Olmesartan Medoxomil (40mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Overview Olmibid Trio 40mg/5mg/12.5mg Tablet
Hypertensia-Trio (40mg/5mg/12.5mg) tablets combine multiple agents to manage hypertension when monotherapy proves insufficient. This formulation effectively reduces elevated blood pressure, mitigating the risk of future strokes and heart attacks. Hypertensia-Trio may be ingested with or without food, with dosage adjusted based on individual response and health status. Consistent daily administration at the same time is crucial. Continue treatment as directed by your physician; discontinuation may increase stroke or heart attack risk. This medication includes a diuretic, potentially increasing urination, thus avoid consumption within four hours of bedtime. Regular use, even during symptom-free periods, maximizes therapeutic benefits; hypertension often presents asymptomatically. Common side effects encompass ankle edema, cephalgia, vertigo, fatigue, and altered taste perception. Report persistent, worsening, or bothersome side effects to your physician. Maintain adequate hydration to counteract potential side effects such as myalgia, xerostomia, and polydipsia. Prior to initiation, inform your doctor of any renal or hepatic dysfunction, pregnancy, breastfeeding, or concurrent medication use, especially those targeting hypertension or cardiac conditions. Regular monitoring of blood pressure, renal function, electrolytes, and blood glucose levels is essential to ensure optimal therapeutic efficacy.
Primary Ingredients of Olmibid Trio 40mg/5mg/12.5mg Tablet
No text was provided to rephrase. Please provide the text you wish to have rewritten.
Uses of Olmibid Trio 40mg/5mg/12.5mg Tablet
Elevated arterial blood pressure
Major Benefits of Olmibid Trio 40mg/5mg/12.5mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Swallow the Olmibid Trio 40mg/5mg/12.5mg tablet whole; do not crush, chew, or break it. This medication can be administered with or without food, but consistent timing is recommended.
Common Side effects of Olmibid Trio 40mg/5mg/12.5mg Tablet:
- Headache
- Dizziness
- Nausea
- Upper respiratory tract infection
- Fatigue
- Urinary tract infection
- Diarrhea
- Joint swelling
- Peripheral edema
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Muscle spasm
- Hypotension (low blood pressure)
- Increased creatinine level in blood
- Increased blood urea
- Increased uric acid level in blood
How to use Olmibid Trio 40mg/5mg/12.5mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Swallow the 40mg/5mg/12.5mg Olmibid Trio tablet whole; avoid chewing, crushing, or fracturing it. This medication can be ingested with or without food, however, consistent daily timing is recommended.
How Olmibid Trio 40mg/5mg/12.5mg Tablet works:
The tablet Olmibid Trio (40mg/5mg/12.5mg) combines olmesartan medoxomil, amlodipine, and hydrochlorothiazide to control hypertension. Olmesartan medoxomil (an ARB) and amlodipine (a CCB) act synergistically to dilate blood vessels, reducing blood pressure. Hydrochlorothiazide, a diuretic, further lowers blood pressure by promoting fluid excretion and, over time, enhancing vasodilation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Olmibid Trio 40mg/5mg/12.5mg tablets with alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
Using Olmibid Trio 40mg/5mg/12.5mg tablets during pregnancy poses a confirmed risk to the fetus. Nevertheless, a physician might exceptionally prescribe it in emergencies where the potential benefits outweigh the hazards. Physician consultation is mandatory.
Breast feedingCONSULT YOUR DOCTOR
The use of Olmibid Trio 40mg/5mg/12.5mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Olmibid Trio 40mg/5mg/12.5mg Tablets, which can induce side effects including dizziness, headaches, nausea, or fatigue. These side effects can compromise concentration and driving safety.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Olmibid Trio 40mg/5mg/12.5mg tablets. Dosage modification may be necessary; physician consultation is advised. Olmibid Trio 40mg/5mg/12.5mg tablets are not recommended for individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should exercise caution when using Olmibid Trio 40mg/5mg/12.5mg tablets. Dosage modification of Olmibid Trio 40mg/5mg/12.5mg tablets may be necessary. Physician consultation is advised.
What if you forget to take Olmibid Trio 40mg/5mg/12.5mg Tablet :
Olmibid Trio 40mg/5mg/12.5mg Tablet: Take a missed dose immediately if you remember. If your next dose is imminent, omit the missed one and resume your usual dosing regimen. Never take more than the prescribed amount at one time.
Facts to Know About Olmibid Trio 40mg/5mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
